Macquarie raises Imax price target to $48, maintains Outperform
Macquarie analyst Chad Beynon maintained an Outperform rating on Imax and raised the price target to $48 from $46, signaling a positive outlook for the stock.
*this image is generated using AI for illustrative purposes only.
Macquarie analyst Chad Beynon has maintained an Outperform rating on Imax (NYSE: IMAX) and raised the price target to $48 from $46. The revised target indicates increased confidence in the company's stock performance potential.
Rating and Target Details
The firm's decision to upgrade the price target comes as part of a routine evaluation of Imax's market position. The previous target of $46 has been adjusted upward by $2 to the new level of $48.
| Metric | Value |
|---|---|
| Rating | Outperform |
| Previous Price Target | $46 |
| New Price Target | $48 |
The Outperform rating suggests that Imax is expected to deliver returns above the average market performance. The specific drivers behind the target increase were not disclosed in the filing.
What specific factors might drive Imax's stock to surpass the new $48 price target?
How could upcoming film releases impact Imax's revenue and market position in the near term?
What risks could potentially hinder Imax from achieving the revised price target?
16
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
